These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7797904)

  • 21. Recombinant amino terminal fragment of bactericidal/permeability-increasing protein prevents hemodynamic responses to endotoxin.
    Ammons WS; Kung AH
    Circ Shock; 1993 Nov; 41(3):176-84. PubMed ID: 8269647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils.
    Ooi CE; Weiss J; Doerfler ME; Elsbach P
    J Exp Med; 1991 Sep; 174(3):649-55. PubMed ID: 1875165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endotoxin-binding and -neutralizing properties of recombinant bactericidal/permeability-increasing protein and monoclonal antibodies HA-1A and E5.
    Marra MN; Thornton MB; Snable JL; Wilde CG; Scott RW
    Crit Care Med; 1994 Apr; 22(4):559-65. PubMed ID: 8143464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees.
    van Leenen D; van der Poll T; Levi M; ten Cate H; van Deventer SJ; Hack CE; Aarden LA; ten Cate JW
    J Immunol; 1993 Aug; 151(4):2318-25. PubMed ID: 8345209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bactericidal/permeability-increasing protein inhibits induction of macrophage nitric oxide production by lipopolysaccharide.
    Corradin SB; Heumann D; Gallay P; Smith J; Mauël J; Glauser MP
    J Infect Dis; 1994 Jan; 169(1):105-11. PubMed ID: 8277172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design of a potent novel endotoxin antagonist.
    Uknis ME; Wasiluk KR; Acton RD; Klaerner HG; Dahlberg PS; Ilyina EE; Haseman JR; Gray BH; Mayo KH; Dunn DL
    Surgery; 1997 Aug; 122(2):380-5. PubMed ID: 9288144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human neutrophil bactericidal/permeability-increasing protein reduces mortality rate from endotoxin challenge: a placebo-controlled study.
    Fisher CJ; Marra MN; Palardy JE; Marchbanks CR; Scott RW; Opal SM
    Crit Care Med; 1994 Apr; 22(4):553-8. PubMed ID: 8143463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis of hemorrhage-induced bacteria/endotoxin translocation in rats. Effects of recombinant bactericidal/permeability-increasing protein.
    Yao YM; Bahrami S; Leichtfried G; Redl H; Schlag G
    Ann Surg; 1995 Apr; 221(4):398-405. PubMed ID: 7726676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Release of bactericidal/permeability-increasing protein in experimental endotoxemia and clinical sepsis. Role of tumor necrosis factor.
    von der Möhlen MA; van der Poll T; Jansen J; Levi M; van Deventer SJ
    J Immunol; 1996 Jun; 156(12):4969-73. PubMed ID: 8648149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. rBPI23 attenuates endotoxin-induced cardiovascular depression in awake rabbits.
    Koyama S; Shibamoto T; Ammons WS; Saeki Y
    Shock; 1995 Jul; 4(1):74-8. PubMed ID: 7552782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of gram-negative bacteria tested in neonatal cord blood ex vivo.
    Levy O; Sisson RB; Kenyon J; Eichenwald E; Macone AB; Goldmann D
    Infect Immun; 2000 Sep; 68(9):5120-5. PubMed ID: 10948134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity.
    Marra MN; Wilde CG; Griffith JE; Snable JL; Scott RW
    J Immunol; 1990 Jan; 144(2):662-6. PubMed ID: 2295804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of the acute-phase cytokine, hepatocyte-stimulating factor/interleukin 6, in the circulation of horses treated with endotoxin.
    MacKay RJ; Lester GD
    Am J Vet Res; 1992 Aug; 53(8):1285-9. PubMed ID: 1510298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant human bactericidal/permeability-increasing protein (rBPI23) is a universal lipopolysaccharide-binding ligand.
    Appelmelk BJ; An YQ; Thijs BG; MacLaren DM; de Graaff J
    Infect Immun; 1994 Aug; 62(8):3564-7. PubMed ID: 8039930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration, and presence of septic serum.
    Prins JM; Kuijper EJ; Mevissen ML; Speelman P; van Deventer SJ
    Infect Immun; 1995 Jun; 63(6):2236-42. PubMed ID: 7768603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver failure induces a systemic inflammatory response. Prevention by recombinant N-terminal bactericidal/permeability-increasing protein.
    Boermeester MA; Houdijk AP; Meyer S; Cuesta MA; Appelmelk BJ; Wesdorp RI; Hack CE; Van Leeuwen PA
    Am J Pathol; 1995 Nov; 147(5):1428-40. PubMed ID: 7485405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees.
    van der Poll T; Levi M; Hack CE; ten Cate H; van Deventer SJ; Eerenberg AJ; de Groot ER; Jansen J; Gallati H; Büller HR
    J Exp Med; 1994 Apr; 179(4):1253-9. PubMed ID: 8145042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional domains of recombinant bactericidal/permeability increasing protein (rBPI23).
    Little RG; Kelner DN; Lim E; Burke DJ; Conlon PJ
    J Biol Chem; 1994 Jan; 269(3):1865-72. PubMed ID: 8294435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of recombinant bactericidal/permeability-increasing protein on pulmonary cytokine mRNA expression in rats following hemorrhage and resuscitation].
    Yao Y; Sheng Z; Shi Z
    Zhonghua Wai Ke Za Zhi; 1997 Jul; 35(7):389-91. PubMed ID: 10677969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential priming for endotoxin-induced circulating cytokine production by tumor necrosis factor-alpha and interleukin 1 beta.
    Le Contel C; Vinit MA; Parant FJ; Parant MA
    Cytokine; 1990 Sep; 2(5):375-80. PubMed ID: 2103335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.